Adler Reid G. has filed 7 insider transactions across 1 company since December 2023.
Most recent transaction: a grant/award of 18753 shares of Vistagen Therapeutics, Inc. ($VTGN) on April 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 7, 2026 | Vistagen Therapeutics, Inc. | $VTGN | Adler Reid G. | Chief Legal Officer | A | Incentive Stock Option (right to buy) | 18753 | $0.00 | 18,753.0000 | 42,234,405 | 9999.99% | 0.04% |
| April 7, 2026 | Vistagen Therapeutics, Inc. | $VTGN | Adler Reid G. | Chief Legal Officer | A | Non-Qualified Stock Option (right to buy) | 56247 | $0.00 | 56,247.0000 | 42,234,405 | 9999.99% | 0.13% |
| June 30, 2025 | Vistagen Therapeutics, Inc. | $VTGN | Adler Reid G. | Chief Legal Officer | A | Common Stock | 7541 | $1.70 | 24,050.0000 | 29,157,733 | 45.68% | 0.03% |
| June 23, 2025 | Vistagen Therapeutics, Inc. | $VTGN | Adler Reid G. | Chief Legal Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 29,157,733 | 9999.99% | 0.34% |
| June 28, 2024 | Vistagen Therapeutics, Inc. | $VTGN | Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | A | Common Stock | 4854 | $2.96 | 16,509.0000 | 19,354,500 | 41.65% | 0.03% |
| June 24, 2024 | Vistagen Therapeutics, Inc. | $VTGN | Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | A | Stock Option (Right to Buy) | 170000 | $0.00 | 170,000.0000 | 19,354,500 | 9999.99% | 0.88% |
| Dec. 29, 2023 | Vistagen Therapeutics, Inc. | $VTGN | Adler Reid G. | CHF CORP DEVEL OFF, GEN COUNS | A | Common Stock | 167 | $1.72 | 11,655.0000 | 0 | 1.45% | 0.00% |